Get Hepatitis C Treatment Online

Yes. Modern direct-acting antiviral (DAA) regimens cure more than 95% of people with chronic hepatitis C. A sustained virologic response, defined as undetectable HCV RNA 12 weeks after completing treatment, is considered a functional cure.

Most treatment-naive patients without cirrhosis complete therapy in 8 to 12 weeks, depending on the medication chosen and the hepatitis C genotype. Some patients with advanced liver disease or prior treatment failure may require a longer course.

Genotype testing is helpful and guides medication selection, but some newer pangenotypic regimens like Mavyret and Epclusa are effective against all six major genotypes, so treatment can sometimes proceed without genotype results.

Key tests include HCV RNA (viral load), HCV genotype, liver function tests (ALT and AST), a complete blood count, and assessment of liver fibrosis or cirrhosis, often using a FIB-4 score, elastography, or imaging. Your physician will advise which tests are needed at baseline and during follow-up.

Yes. DAA medications can interact significantly with other drugs, including certain acid reducers, statins, anticonvulsants, and HIV medications. It is important to share a complete list of all your medications and supplements with your physician before starting treatment.

Yes, and it is strongly recommended. People with chronic Hepatitis C who are not already immune to Hepatitis A and B should be vaccinated, because co-infection with other hepatitis viruses can worsen liver disease.

Doctronic uses AI-powered evaluation to gather your medical history and symptoms, then connects you with a licensed physician who reviews your information and creates a personalized treatment plan, which may include prescriptions, lab orders, or specialist referrals.

Yes. Doctronic's platform is staffed by licensed physicians, is HIPAA-compliant, and all care decisions are doctor-reviewed and audited. Our telehealth services are available to adults 18 and older in any U.S. state.